Werbung
Werbung
IMNM
Immunome, Inc.
21.09
USDGesponsert
+0.64
+3.11%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
21.21
+0.13
+0.61%
IMNM Ergebnisberichte
Positives Überraschungsverhältnis
IMNM übertreffen die 7 der letzten 20Schätzungen.
35%
Nächster Bericht
Datum des nächsten Berichts
17. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$340.00K
/-$0.61
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/-6.15%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-87.58%
/-52.34%
Immunome, Inc. earnings per share and revenue
On 06. Nov. 2025, IMNM reported earnings of -0.65 USD per share (EPS) for Q3 25, missing the estimate of -0.58 USD, resulting in a -10.98% surprise. Revenue reached --, compared to an expected 816.00 tausend, with a -100.00% difference. The market reacted with a -1.68% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 15 analysts forecast an EPS of -0.61 USD, with revenue projected to reach 340.00 tausend USD, implying an decrease of -6.15% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Immunome, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Immunome, Inc. reported EPS of -$0.65, missing estimates by -10.98%, and revenue of $0.00, -100% below expectations.
How did the market react to Immunome, Inc.'s Q3 2025 earnings?
The stock price moved down -1.68%, changed from $15.50 before the earnings release to $15.24 the day after.
When is Immunome, Inc. expected to report next?
The next earning report is scheduled for 17. März 2026.
What are the forecasts for Immunome, Inc.'s next earnings report?
Based on 15
analysts, Immunome, Inc. is expected to report EPS of -$0.61 and revenue of $340.00K for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung